ReviewFrontiers in immunology2026
Adjuvant chemotherapy combined with pembrolizumab immunotherapy for primary triple-negative neuroendocrine carcinoma of the breast: a case report and literature review.
Xin Shen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.